CPHI Webinar Series

Pathway to $10/g Biologics Production: Reshaping the Biomanufacturing Landscape

Tuesday 18th February, 2025
3pm BST /4pm CET
What will this webinar address?

Biologics have become mainstays of modern medicine. Despite the therapeutics benefits over traditional treatment, their high price limits their accessibility to the developed countries with average GDP per capita of $12,000 or above, which covers only 2 billion people. Current production costs for monoclonal antibody (mAb) are $100 per gram or more. If the cost can be reduced to $10 per gram, the threshold for biotherapeutics accessibility could be lowered to $2,500 GDP per capita, which means 6 billion people shall benefit from the biologic medications.

Biologic medications are expensive due to complexities of their development, production, and regulation. Unlike traditional drugs, biologics are derived from living cells, requiring strict environmental controls to ensure quality and making their manufacturing processes intricate and costly. Meanwhile, biologics manufacturing facility demands significant investment of time and capital, which limits competition and lets manufacturers set high prices to recoup their costs. These combined factors make biologics some of the most expensive treatments available. In this webinar, Dr. Peng Jiao, founder and CEO of BiBo Pharma, will show you the pathway to $10/g biologics production and how BiBo Pharma shall redefine the biomanufacturing landscape!

Key Takeaways:

  • The world’s first and largest 30kL ultra-large production line
  • The revolutionary PanFlex-Engineering: build up a GMP facility at ½ time and ½ cost
  • BiBo leads the incoming 4th revolutionary wave of biologics manufacturing

James Reidy - Moderator
Senior Conference Producer
Pharma, Informa Markets

James is an experienced events producer, who has developed and led multiple events across the life science industry for leading events organisations, while keeping the highest standards in terms of quality and delivery. Now at Informa Markets as Senior Content Producer, James oversees the content for CPHI North America and CPHI webinar series, helping in creating cutting edge sessions and providing guidance in creating interactive and educational talks.

Dr. Peng Jiao
Founder, President & CEO
BiBo Pharma

Peng Jiao, Ph.D. in 1998, has almost 30 years of experience in the fields of biopharmaceuticals and biotechnology with the deep knowledge in mammalian cell culture and microbial fermentation process development, technology transfer, scale-up/scale-down, large-scale production, bioreactor design, plant design and construction. In recent years, he has been focusing on new generation technologies for bioprocesses and biomanufacturing, and next generation engineering technologies for plant construction and operation.

In the early stages of his career, he led dozens of product development and production projects, and has successfully achieved commercial production of over ten products, including small molecules and biologics products.

In 2007, Dr. Jiao first came up the PanFlex® concept. With years of iterative development, the PanFlex® system has been applied (or partially applied) in the design and construction of more than 15 biomanufacturing plants, including the P03 GMP manufacturing facility with the world's first 30,000-litre ultra-large product lines within 15 months from 2022 to 2023. Now Dr. Jiao is leading his team to develop the next generation “Mega-factory” and is expected to lead the 4th wave of biological manufacturing for the benefit of patients worldwide.

He had teaching and post-doctoral experience at Tsinghua University and Massachusetts Institute of Technology from his early days. After that, he worked at several biopharmaceutical companies, such as Novartis and Lonza Biologics. In 2014, he founded Boston Institute of Biotechnology (BIB) and BiBo Pharma.

This webinar is brought to you by

Overview
Pathway to $10/g Biologics Production: Reshaping the Biomanufacturing Landscape
  • Tuesday 18th February, 2025
  • 3pm BST / 4pm CET
  • 60 minutes
  • Free